×
Net revenue reached $11.4 billion , up 5.5% year over year and 7.1% on an organic basis. Adjusted diluted EPS (earnings per share) rose 5.4% to a quarterly record of $2.36 , or 5.8% excluding currency.
Philip Morris International (PM) is scheduled to report third-quarter 2026 results before the market opens on Wednesday, October 21, 2026. Company guidance points to adjusted diluted earnings per share (EPS) of $2.20 to $2.25, below Wall Street consensus estimates of roughly $2.29.
The central price target of $4.90 is the arithmetic mean of two verified analyst price targets for Ispire Technology Inc. (ISPR) . The two current targets range widely, from $3.30 (BTIG) to $6.50 (Roth MKM), reflecting genuine disagreement about the company's growth trajectory.
Nicotine-first pivot: Ispire is shifting away from lower-margin legacy cannabis hardware toward regulated nicotine products, original design manufacturing (ODM, where it designs and builds products for other brands), and technology licensing. Malaysia ramp: A licensed Malaysian manufacturing facility is now operational, offering a roughly 25% tariff advantage versus China for U.S.-bound products and a platform to serve major tobacco customers.
ISPR shares slipped -0.68% to $1.46 in early regular-session trading, easing from the prior close of $1.47. The move occurred during market hours on very light volume, signaling limited conviction rather than a company-specific catalyst.
XXII is down -38.89% during regular trading to roughly $1.43, extending an after-hours slide that began after Wednesday's +29% surge to a $2.34 close. The move is driven by a report that the FDA and administration plan to fast-track authorization for newer tobacco products such as flavored vapes, threatening 22nd Century's status as the only FDA-authorized reduced-nicotine cigarette maker (VLN).
TPB fell -9.64% to about $61.57 during regular trading on Sept. 21, 2026, versus the prior close of $68.14. The drop followed the morning announcement that CEO Graham Purdy is stepping down Oct. 1 for personal reasons, with Executive Chairman David Glazek named as his successor.
Turning Point Brands recently traded near $75, placing the $100 target roughly 33% above current levels — a meaningful but not unrealistic gap. The $100 mark is a natural psychological milestone, and TPB traded well above it as recently as early 2026, peaking near $147 in February.
MO plunged -8.34% during regular trading after reporting Q2 2026 results that missed profit estimates, with the selloff accelerating sharply from a -3% premarket decline. Adjusted EPS came in at $1.48, missing the $1.50 consensus, as macroeconomic pressure drove smokers toward cheaper alternatives, eroding premium-brand demand.
Philip Morris International reported Q2 2026 net revenues exceeding $11 billion for the first time, reflecting close to 8% organic growth. Adjusted diluted earnings per share rose 15% in dollar terms and 14% on a currency-neutral basis.
Philip Morris International Inc. is a leading international tobacco company focused on manufacturing and selling cigarettes and other nicotine-containing products outside the United States. Its core business model centers on combustibles such as PM brands like Marlboro and Parliament, while rapidly expanding into smoke-free alternatives including heated tobacco systems like IQOS and nicotine pouches such as ZYN. The company operates primarily in the global tobacco industry, holding a strong competitive position through premium branding, extensive distribution networks, and innovation in reduced-risk products. These fundamentals, particularly the growing contribution from smoke-free businesses which accounted for a rising share of revenues, help explain the recent positive stock behavior as investors reward progress toward a diversified, lower-risk portfolio.
Altria Group (MO) stock rose approximately +13% over the past 30 days, driven primarily by a strong Q1 2026 earnings beat that propelled shares sharply higher at month-end. Over the past quarter, shares gained around +16%, reflecting recovery from earlier lows amid consistent operational performance and a shift toward smokefree products.
Analysts expect Q1 2026 adjusted EPS of $1.24, a slight increase from $1.23 in the year-ago quarter. Consensus revenue estimate stands at $4.56 billion, reflecting 0.9% year-over-year growth.
Philip Morris International Inc. (PM) stands as a leading global tobacco company, focused on manufacturing and selling cigarettes, smoke-free products such as heated tobacco and nicotine pouches, and emerging alternatives. The core of its business model revolves around transitioning adult smokers to reduced-risk products, with smoke-free offerings like IQOS and Zyn generating 41.5% of total net revenues exceeding $40 billion in 2025. Operating in over 180 markets, PM maintains a strong competitive position in the tobacco industry against peers like British American Tobacco (BTI), thanks to its scale, innovation in smoke-free technologies, and robust dividend yield. These fundamentals provide resilience, but regulatory hurdles in key markets like the U.S. and India have driven recent stock price volatility, as investors balance transition progress against approval risks.
Shares of Philip Morris International fell approximately 8% during intraday trading on April 1, 2026, dropping from a prior close of $165.34 to around $152.11. A sharp, broad-based market selloff — amplified by renewed trade policy tensions — is acting as the primary macro catalyst behind the decline.
Shares of Turning Point Brands (TPB) are falling sharply intraday on April 1, 2026, shedding approximately 15% from their prior session close of roughly $87.41, placing the stock near $74.30. The primary catalyst is broad investor risk-off selling tied to mounting trade-policy uncertainty ahead of President Trump's sweeping tariff announcements scheduled for April 2 — a day the administration has branded "Liberation Day".
Smoke-free products accounted for 41.5% of total net revenues in 2025, with shipment volumes rising 12.8%.
An AI-driven comparison of Philip Morris (PM) and British American Tobacco (BTI) points to Philip Morris as the more attractive investment for 2026. The analysis highlights PM’s accelerated transition toward smoke-free products, which positions the company for sustainable growth as global regulations continue to pressure traditional combustible tobacco.
Join us as we dissect the Tobacco sector's impressive strong performance, led by $PM, $MO, $BTI, $VGR, and $UVV. Uncover the key factors fueling this remarkable growth in our latest market analysis.
The Tobacco industry has demonstrated a remarkable upswing in its performance over the past week, with a significant increase of +4.31%. This positive momentum is reflected across a group of prominent tickers within the industry, including XXII, GNLN, RLX, KAVL, and HPCO.